| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/05/2011 | CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof |
| 07/05/2011 | CA2380066C Antitumor antibodies, proteins, and uses thereof |
| 07/05/2011 | CA2319687C Method for purifying prpres from a biological sample and applications |
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 07/05/2011 | CA2204636C Diagnostic method and kit for determining kell blood group genotype |
| 06/30/2011 | WO2011079307A2 Methods and compositions for treating neurological disorders |
| 06/30/2011 | WO2011079296A2 Photoconductive sensor materials for detection of explosive vapor |
| 06/30/2011 | WO2011079280A2 Compositions and methods for diagnosing and treating kidney disorders in a canine |
| 06/30/2011 | WO2011079214A1 Diagnosis and treatment of reverse cholesterol transport deficiency-related diseases |
| 06/30/2011 | WO2011079188A2 Protein modification from the oxidation of clickable polyunsaturated fatty acid analogs |
| 06/30/2011 | WO2011079176A2 Microfluidic systems and methods for reducing the exchange of molecules between droplets |
| 06/30/2011 | WO2011079166A2 Device for identifying oral conditions |
| 06/30/2011 | WO2011079164A1 Diagnostic oral device |
| 06/30/2011 | WO2011079161A1 Method for assessing water resistance of an antiperspirant product |
| 06/30/2011 | WO2011079080A1 Peracid and 2-hydroxy organic acid compositions and methods for sanitation and disease prevention |
| 06/30/2011 | WO2011079079A1 Peracid and 2-hydroxy organic acid compositions and methods for treating items |
| 06/30/2011 | WO2011079064A1 Methods and kits for identyfing human adenovirus serotypes |
| 06/30/2011 | WO2011078980A1 A method for performing a blood count and determining the morphology of a blood smear |
| 06/30/2011 | WO2011078880A2 Solution analysis using atmospheric pressure ionization techniques |
| 06/30/2011 | WO2011078800A1 Method for the detection of an analyte |
| 06/30/2011 | WO2011078794A1 Sers-based analyte detection |
| 06/30/2011 | WO2011078778A1 Method for assessing the sensitisation capability of a compound |
| 06/30/2011 | WO2011078777A1 Method of analysis with improved mixing |
| 06/30/2011 | WO2011078760A1 Procedure for controlling the pulp quality from refiners |
| 06/30/2011 | WO2011078714A1 Non-destructive and non-invasive method for inspecting vegetable materials involving the use of electromagnetic radiation |
| 06/30/2011 | WO2011078713A1 Surface plasmon resonance detection system |
| 06/30/2011 | WO2011078704A1 Lysimeter with minimally disturbing insertion via sidewall |
| 06/30/2011 | WO2011078692A1 Quality sensor apparatus |
| 06/30/2011 | WO2011078650A2 Method for fabricating nanofluidic channels |
| 06/30/2011 | WO2011078495A2 Chemo-sensitive prediction method for snp |
| 06/30/2011 | WO2011078443A1 Detecting marker for gastric cancer and detecting method using the same marker |
| 06/30/2011 | WO2011078384A1 Method for measuring human insulin and measurement reagent |
| 06/30/2011 | WO2011078307A1 Method for measuring substance p in urine sample |
| 06/30/2011 | WO2011078301A1 Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein |
| 06/30/2011 | WO2011078115A1 DEVICE HAVING SOLID-LIQUID SEPARATION FUNCTION, μ-TAS DEVICE, AND SOLID-LIQUID SEPARATION METHOD |
| 06/30/2011 | WO2011078094A1 Method for detection and quantification of wheat endogenous gene |
| 06/30/2011 | WO2011078028A1 Liquid characteristic analyzing apparatus |
| 06/30/2011 | WO2011077838A1 Silica nanoparticles having fluorescent substance confined therein, and labeling agent for biosubstance |
| 06/30/2011 | WO2011077757A1 Storage device for liquid to be tested |
| 06/30/2011 | WO2011077751A1 Composition for labeling tissues of central nervous system, method for labeling tissues of central nervous system, and screening method using the composition for labeling tissues of central nervous system |
| 06/30/2011 | WO2011077733A1 Transnasal labeling composition for tissues of central nervous system, and labeling method and screening method each using the transnasal labeling composition for tissues of central nervous system |
| 06/30/2011 | WO2011077728A1 Method for determining hemagglutination image and device for determining hemagglutination image |
| 06/30/2011 | WO2011077399A1 Methods for analyzing components of glycan containing microparticles |
| 06/30/2011 | WO2011077342A1 Method |
| 06/30/2011 | WO2011077333A1 Analyte measurement apparatus and method |
| 06/30/2011 | WO2011077306A1 Apparatuses and methods for measuring uv absorption rate |
| 06/30/2011 | WO2011077271A1 Methods and apparatus for characterization of a petroleum reservoir employing compositional analysis of fluid samples and rock core extract |
| 06/30/2011 | WO2011077258A1 Streptavidin and biotin- based antigen delivery system |
| 06/30/2011 | WO2011077165A1 Prognostic marker |
| 06/30/2011 | WO2011077133A2 Method of treatment and screening method |
| 06/30/2011 | WO2011077130A1 Biomarkers |
| 06/30/2011 | WO2011077129A1 Biomarkers |
| 06/30/2011 | WO2011076970A1 Bioactive surface capable of genetically modifying biological cells or tissues and use thereof |
| 06/30/2011 | WO2011076951A1 Plasmonic force manipulation in nanostructures |
| 06/30/2011 | WO2011076932A1 Receptors of rspo2 and rspo3 |
| 06/30/2011 | WO2011076888A2 System and method for online detection of enclosures in mineral wool, especially during production |
| 06/30/2011 | WO2011076860A1 Device, method, and system for the quantitative detection of the presence of multiple target analytes |
| 06/30/2011 | WO2011076859A1 Method and kit for determining metabolites on dried blood spot samples |
| 06/30/2011 | WO2011076854A1 CLEAVAGE OF β-AMYLOID PRECURSOR PROTEIN |
| 06/30/2011 | WO2011076803A1 Measuring device and method for analysing a test gas by means of an infrared absorption spectroscopy |
| 06/30/2011 | WO2011076413A1 Means and methods for detecting plasmodia and for screening or diagnosing drug resistance or altered drug responsiveness of plasmodia |
| 06/30/2011 | WO2011076362A1 Test strip container |
| 06/30/2011 | WO2011076265A1 Assembly and method for measuring pourable products |
| 06/30/2011 | WO2011076015A1 Immunochromatographic test strip with barcode layer |
| 06/30/2011 | WO2011076014A1 Intelligent apparatus for identifying and analyzing immunochromatographic test strip |
| 06/30/2011 | WO2011076013A1 Method and system for intelligently identifying and reading immunochromatographic test strip |
| 06/30/2011 | WO2011075873A1 Pancreatic cancer markers, and detecting methods, kits, biochips thereof |
| 06/30/2011 | WO2011075842A1 Metabolomic biomarker signature of pre-eclampsia risk |
| 06/30/2011 | WO2011075789A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | WO2011075773A1 An assay for measuring cell-mediated immunoresponsiveness |
| 06/30/2011 | WO2011057239A3 Secretory protein biomarkers for high efficiency protein expression |
| 06/30/2011 | WO2011057214A3 Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
| 06/30/2011 | WO2011056958A3 Detection of traumatic brain injury |
| 06/30/2011 | WO2011055250A3 System and method of monitoring breathing |
| 06/30/2011 | WO2011054997A3 Monoclonal antibody that recognises the gapdh protein of candida famata |
| 06/30/2011 | WO2011054992A4 Method for the chemical modification of tantalum pentoxide surfaces |
| 06/30/2011 | WO2011051271A3 Prostate tumor markers and methods of use thereof |
| 06/30/2011 | WO2011049442A3 Blood coagulation status measurement in saliva |
| 06/30/2011 | WO2011045456A3 Novel biomarkers of disease histopathology |
| 06/30/2011 | WO2011041670A3 Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells |
| 06/30/2011 | WO2011040876A9 Screening of binders on immobilized native membrane proteins |
| 06/30/2011 | WO2011039430A3 Disposable device for the detection of particles of interest, such as biological entities, detection system comprising said device and method for using same |
| 06/30/2011 | WO2011033290A3 Dual fluorescence assay for determining viability of parasitic or non- parasitic worms |
| 06/30/2011 | WO2011031438A3 Porcine torque teno virus vaccines and diagnosis |
| 06/30/2011 | WO2011027351A3 Diagnosis of gastrointestinal cancers through glycome analysis |
| 06/30/2011 | WO2011022064A3 Analytic device with 2d scanning mirror reader |
| 06/30/2011 | WO2011017660A3 Magnetic carbon nanotube based biodetection |
| 06/30/2011 | WO2011017145A3 Biomarkers for gossypol chemotherapy and methods of treating disease |
| 06/30/2011 | WO2011012268A8 Use of mimecan in the assessment of heart failure |
| 06/30/2011 | WO2011011738A3 Illumination in biotech instruments |
| 06/30/2011 | WO2011010870A3 Genetic marker for predicting the survival of a patient with early-stage lung cancer, and method for predicting survival using same |
| 06/30/2011 | WO2011009848A3 Therapeutic use of probiotics |
| 06/30/2011 | WO2011008992A3 Peptides whose uptake in cells is controllable |
| 06/30/2011 | WO2011007290A3 Multiple component materials having a color-changing composition |
| 06/30/2011 | WO2010140824A9 Composition for diagnosis and determination of prognosis of hepatocellular carcinoma |
| 06/30/2011 | US20110162113 Antibodies |
| 06/30/2011 | US20110162092 Composition comprised of akap12 and uses of akap12 mutant zebrafish as an animal model |
| 06/30/2011 | US20110161265 Methods, systems, and software for identifying functional bio-molecules |
| 06/30/2011 | US20110161256 Products and processes for analyzing octane content |
| 06/30/2011 | US20110161013 Method for determining heat boundary value conditions of red blood cells in the neighborhood of myocardium |